Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients

dc.contributor.authorAkkiz, Hikmet
dc.contributor.authorCarr, Brian I.
dc.contributor.authorYalcin, Kendal K.
dc.contributor.authorGuerra, Vito
dc.contributor.authorKuran, Sedef
dc.contributor.authorAltintas, Engin
dc.contributor.authorDoran, Figen
dc.date.accessioned2026-08-12T17:08:14Z
dc.date.issued2018
dc.departmentFırat Üniversitesi
dc.description.abstractA large cohort of hepatocellular carcinoma (HCC) patients from several collaborating Turkish institutions were examined for the tumor parameters of maximum diameter (MTD), portal vein thrombosis (PVT), and alpha-fetoprotein (AFP) levels. A relationship was found between MTD and blood platelet levels. Patients with large >= 5 cm tumors who had normal platelet levels had significantly larger tumors, higher percent of PVT, and significantly lower blood total bilirubin and liver cirrhosis than similar >= 5 cm tumor patients having thrombocytopenia. A comparison of patients with and without PVT showed significantly larger tumors, greater multifocality, blood AFP, and C-reactive protein levels, and, interestingly, lower HDL levels in the patients with PVT. Fifty-eight percent of the total cohort had AFP levels <= 100 IU/mL ( and 42.1% had values <= 20 IU/mL). These patients had significantly smaller tumors, less tumor multifocality and percent PVT, lower total bilirubin, and less cirrhosis. There was considerable geographic heterogeneity within Turkey in the patterns of HCC presentation, with areas of higher and lower hepatitis B virus, hepatitis D virus, cirrhosis, and tumor aggressiveness parameters. Turkish patients thus have distinct patterns of presentation, but the biological relationships between MTD and both platelets and bilirubin levels are similar to the relationships that have been reported in other ethnic patient groups. (C) 2017 S. Karger AG, Basel
dc.description.sponsorshipNIH [CA 82723]
dc.description.sponsorshipThis work was supported in part by NIH grant CA 82723 (B.I.C.).
dc.identifier.doi10.1159/000484564
dc.identifier.endpage124
dc.identifier.issn0030-2414
dc.identifier.issn1423-0232
dc.identifier.issue2
dc.identifier.orcid0000-0001-9745-8875
dc.identifier.orcid0000-0001-5302-8953
dc.identifier.orcid0000-0003-0796-1456
dc.identifier.orcid0000-0002-2727-5632
dc.identifier.orcid0000-0002-8336-5472
dc.identifier.orcid0000-0002-8909-2102
dc.identifier.pmid29207378
dc.identifier.startpage116
dc.identifier.urihttps://doi.org/10.1159/000484564
dc.identifier.urihttps://hdl.handle.net/11508/49973
dc.identifier.volume94
dc.identifier.wosWOS:000424018500008
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofOncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectAlbumin
dc.subjectHepatocellular carcinoma
dc.subjectTurkey
dc.subjectalpha-Fetoprotein
dc.subjectTumor mass
dc.subjectAggressiveness
dc.titleCharacteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients
dc.typeArticle

Dosyalar